162 related articles for article (PubMed ID: 12190228)
1. Aspergillosis in liver transplant recipients: successful treatment and improved survival using a multistep approach.
Duchini A; Redfield DC; McHutchison JG; Brunson ME; Pockros PJ
South Med J; 2002 Aug; 95(8):897-9. PubMed ID: 12190228
[TBL] [Abstract][Full Text] [Related]
2. Resolution of invasive central nervous system aspergillosis in a transplant recipient.
Khoury H; Adkins D; Miller G; Goodnough L; Brown R; DiPersio J
Bone Marrow Transplant; 1997 Jul; 20(2):179-80. PubMed ID: 9244425
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.
Linden P; Williams P; Chan KM
Clin Transplant; 2000 Aug; 14(4 Pt 1):329-39. PubMed ID: 10945204
[TBL] [Abstract][Full Text] [Related]
4. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Ito JI; Chandrasekar PH; Hooshmand-Rad R
Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
[TBL] [Abstract][Full Text] [Related]
6. Isolated pulmonary aspergillar infection in cardiac transplant recipients: case report and review.
Mayer JM; Nimer L; Carroll K
Clin Infect Dis; 1992 Oct; 15(4):698-700. PubMed ID: 1420684
[TBL] [Abstract][Full Text] [Related]
7. [Invasive aspergillosis].
Caillot D; Mannone L; Kara-Slimane F
Rev Prat; 2001 Apr; 51(7):731-7. PubMed ID: 11387668
[TBL] [Abstract][Full Text] [Related]
8. Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
Roy V; Ali LI; Carter TH; Selby GB
J Infect; 2000 Nov; 41(3):273-5. PubMed ID: 11120619
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Bielorai B; Toren A; Wolach B; Mandel M; Golan H; Neumann Y; Kaplinisky C; Weintraub M; Keller N; Amariglio N; Paswell J; Rechavi G
Bone Marrow Transplant; 2000 Nov; 26(9):1025-8. PubMed ID: 11100285
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.
Cicogna CE; White MH; Bernard EM; Ishimura T; Sun M; Tong WP; Armstrong D
Antimicrob Agents Chemother; 1997 Feb; 41(2):259-61. PubMed ID: 9021176
[TBL] [Abstract][Full Text] [Related]
11. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
12. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B lipid complex for the treatment of recurrent blastomycosis of the brain in a patient previously treated with itraconazole.
Cook PP
South Med J; 2001 May; 94(5):548-9. PubMed ID: 11372815
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients.
Robinson LA; Reed EC; Galbraith TA; Alonso A; Moulton AL; Fleming WH
J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1182-96; discussion 1196-7. PubMed ID: 7776682
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
[TBL] [Abstract][Full Text] [Related]
16. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
[No Abstract] [Full Text] [Related]
17. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
18. Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole.
Hunter AJ; Bryant RE
J Infect; 2002 Apr; 44(3):203-4. PubMed ID: 12099754
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
20. Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient.
Başlar Z; Soysal T; Hanci M; Aygün G; Ferhanoğlu B; Sarioğlu AC; Ulkü B
Bone Marrow Transplant; 1998 Aug; 22(4):404-5. PubMed ID: 9722081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
